Applied DNA Sciences Inc (APDN): Price and Financial Metrics

Applied DNA Sciences Inc (APDN): $0.65

0.01 (-1.14%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add APDN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#158 of 379

in industry

APDN Price/Volume Stats

Current price $0.65 52-week high $1.86
Prev. close $0.66 52-week low $0.52
Day low $0.61 Volume 140,500
Day high $0.72 Avg. volume 75,327
50-day MA $0.62 Dividend yield N/A
200-day MA $1.06 Market Cap 11.04M

APDN Stock Price Chart Interactive Chart >

APDN Stock Summary

  • APPLIED DNA SCIENCES INC's market capitalization of $8,609,387 is ahead of just 4.57% of US-listed equities.
  • For APDN, its debt to operating expenses ratio is greater than that reported by just 12.54% of US equities we're observing.
  • As for revenue growth, note that APDN's revenue has grown -26.43% over the past 12 months; that beats the revenue growth of merely 10.48% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to APPLIED DNA SCIENCES INC, a group of peers worth examining would be GNSS, NURO, RPID, TIVC, and KRMD.
  • APDN's SEC filings can be seen here. And to visit APPLIED DNA SCIENCES INC's official web site, go to www.adnas.com.

APDN Valuation Summary

  • In comparison to the median Healthcare stock, APDN's EV/EBIT ratio is 101.37% lower, now standing at -0.2.
  • Over the past 214 months, APDN's EV/EBIT ratio has gone up 41.8.

Below are key valuation metrics over time for APDN.

Stock Date P/S P/B P/E EV/EBIT
APDN 2023-12-29 0.6 1.7 -0.8 -0.2
APDN 2023-12-28 0.7 1.8 -0.9 -0.2
APDN 2023-12-27 0.6 1.7 -0.9 -0.2
APDN 2023-12-26 0.6 1.7 -0.9 -0.2
APDN 2023-12-22 0.6 1.7 -0.9 -0.2
APDN 2023-12-21 0.6 1.6 -0.8 -0.1

APDN Growth Metrics

    Its 3 year price growth rate is now at -95.34%.
  • Its year over year net income to common stockholders growth rate is now at -5.91%.
  • Its year over year cash and equivalents growth rate is now at -52.87%.
Over the past 34 months, APDN's revenue has gone up $14,353,432.

The table below shows APDN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 19.26572 -7.657918 -7.499602
2022-09-30 18.16868 -8.976706 -8.377996
2022-06-30 17.64909 -10.43016 -12.22587
2022-03-31 15.05304 -9.92572 -14.55064
2021-12-31 11.5773 -12.93411 -14.19865
2021-09-30 9.027738 -13.38795 -14.28644

APDN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • APDN has a Quality Grade of D, ranking ahead of 5.38% of graded US stocks.
  • APDN's asset turnover comes in at 0.427 -- ranking 359th of 563 Business Services stocks.
  • GRNQ, VOLT, and FC are the stocks whose asset turnover ratios are most correlated with APDN.

The table below shows APDN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.427 0.793 -5.931
2021-03-31 0.361 0.820 -6.288
2020-12-31 0.252 0.749 -9.825
2020-09-30 0.163 0.627 -10.610
2020-06-30 0.331 0.731 -7.330
2020-03-31 0.683 0.796 -6.300

APDN Price Target

For more insight on analysts targets of APDN, see our APDN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $17.67 Average Broker Recommendation 1.5 (Moderate Buy)

Applied DNA Sciences Inc (APDN) Company Bio


Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes applications in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications and can be used to fortify brand protection efforts, and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide definitive real-time authentication of molecular tags in the field; and CertainT Supply Chain Platform that provides proof of product claims for materials, items, or products. It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and non-diagnostic COVID-19 pooled surveillance testing to detect instances of COVID-19 in defined populations under the safeCircle trademark. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.


APDN Latest News Stream


Event/Time News Detail
Loading, please wait...

APDN Latest Social Stream


Loading social stream, please wait...

View Full APDN Social Stream

Latest APDN News From Around the Web

Below are the latest news stories about APPLIED DNA SCIENCES INC that investors may wish to consider to help them evaluate APDN as an investment opportunity.

Applied DNA Announces Joint Development Agreement to Integrate Linea(TM) IVT Platform into CDMO Kudo Biotechnology’s mRNA Manufacturing Workflow

- Agreement Seeks to Leverage Linea IVT Platform to Enable Kudo Bio to Offer a Differentiated mRNA Manufacturing Capability with Mitigated dsRNA and Reduced Turnaround Times -STONY BROOK, NY and NEEDHAM, MA / ACCESSWIRE / December 14, 2023 / Applied ...

Yahoo | December 14, 2023

Applied DNA Sciences, Inc. (NASDAQ:APDN) Q4 2023 Earnings Call Transcript

Applied DNA Sciences, Inc. (NASDAQ:APDN) Q4 2023 Earnings Call Transcript December 8, 2023 Operator: Good Day and welcome to the Applied DNA Sciences Fiscal Fourth Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Sanjay Hurry, Head of Investor […]

Yahoo | December 12, 2023

Applied DNA Sciences, Inc. (APDN) Q4 2023 Earnings Call Transcript

Applied DNA Sciences, Inc. (APDN)

Q4 2023 Earnings Conference Call

December 07, 2023 04:30 PM ET

Company Participants

Sanjay Hurry - Head of IR

Beth Jantzen - CFO

James Hayward - Chairman, President and CEO

Clay Shorrock - Chief Legal Officer and Head of Business Development

Conference Call Participants

Jason McCarthy - Maxim Group

Yi Chen - H.C. Wainwright

Presentation

Operator

Good Day and welcome to the Applied DNA Sciences Fiscal Fourth Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded.

I would now like to turn the conference over to Sanjay Hurry, Head of Investor Rela...

SA Transcripts on Seeking Alpha | December 8, 2023

APDN Stock Earnings: Applied DNA Sciences Beats EPS, Misses Revenue for Q4 2023

APDN stock results show that Applied DNA Sciences beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.

InvestorPlace Earnings on InvestorPlace | December 8, 2023

Applied DNA Announces Fourth Quarter Fiscal Year 2023 Financial Results

- Conference Call/Webcast Scheduled for Today at 4:30 PM ET -STONY BROOK, NY / ACCESSWIRE / December 7, 2023 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced consolidated ...

Yahoo | December 7, 2023

Read More 'APDN' Stories Here

APDN Price Returns

1-mo 4.50%
3-mo -26.14%
6-mo -48.82%
1-year -54.23%
3-year -93.29%
5-year -97.64%
YTD 5.38%
2023 -62.84%
2022 -58.71%
2021 -21.18%
2020 21.72%
2019 -73.81%

Continue Researching APDN

Want to see what other sources are saying about Applied Dna Sciences Inc's financials and stock price? Try the links below:

Applied Dna Sciences Inc (APDN) Stock Price | Nasdaq
Applied Dna Sciences Inc (APDN) Stock Quote, History and News - Yahoo Finance
Applied Dna Sciences Inc (APDN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!